The State of Disparities in Opportunistic Infection Prophylaxis for Blacks with HIV/AIDS

Overview

Journal Med Care

Specialty Health Services

Date 2012 Oct 11

PMID 23047780

Citations 2

Authors

Christine U Oramasionwu

Jim M Koeller

Kenneth A Lawson

Carolyn M Brown

Gene D Morse

Christopher R Frei

Affiliations

Soon will be listed here.

Abstract

Objectives: The purpose of this review is to identify and analyze published studies that have evaluated disparities for opportunistic infection (OI) prophylaxis between blacks and whites with human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) in the United States.

Methods: The authors conducted a web-based search of MEDLINE (1950-2009) to identify original research articles evaluating the use of OI prophylaxis between blacks and whites with HIV/AIDS. The search was conducted utilizing the following MeSH headings and search terms alone and in combination: HIV, AIDS, Black, race, ethnicity, disparities, differences, access, opportunistic infection, and prophylaxis. The search was then expanded to include any relevant articles from the referenced citations of the articles that were retrieved from the initial search strategy. Of the 29 articles retrieved from the literature search, 19 articles were excluded.

Results: Ten publications met inclusion criteria, collectively published between 1991 and 2005. The collective time periods of these studies spanned from 1987 to 2001. Four studies identified a race-based disparity in that blacks were less likely than whites to use OI prophylaxis, whereas 5 studies failed to identify such a relationship between race and OI prophylaxis. One study identified disparities for Mycobacterium avium complex prophylaxis, but not for Pneumocystis jiroveci pneumonia prophylaxis.

Conclusions: The evidence regarding race-based disparities in OI prophylaxis is inconclusive. Additional research is warranted to explore potential race-based disparities in OI prophylaxis.

Citing Articles

Utilization of immunological ratios in HIV: Implications for monitoring and therapeutic strategies.

Obeagu E, Obeagu G Medicine (Baltimore). 2024; 103(9):e37354.

PMID: 38428854 PMC: 10906605. DOI: 10.1097/MD.0000000000037354.

Decreased ratio of influenza-specific IgG versus IgM in response to influenza vaccination in antiretroviral-treated HIV-infected African Americans compared to Caucasians, and its direct correlation with the percentages of peripheral Tfh cells.

Ma P, Luo Z, Qian J, Yan Z, Zhang L, Martin L Vaccine. 2020; 38(8):1998-2004.

PMID: 31948820 PMC: 7333243. DOI: 10.1016/j.vaccine.2020.01.002.

References

Oramasionwu C, Skinner J, Ryan L, Frei C . Disparities in antiretroviral prescribing for blacks and whites in the United States. J Natl Med Assoc. 2009; 101(11):1140-4. DOI: 10.1016/s0027-9684(15)31110-x. View

Paez K, Allen J, Beach M, Carson K, Cooper L . Physician cultural competence and patient ratings of the patient-physician relationship. J Gen Intern Med. 2009; 24(4):495-8. PMC: 2659158. DOI: 10.1007/s11606-009-0919-7. View

Oramasionwu C, Hunter J, Skinner J, Ryan L, Lawson K, Brown C . Black race as a predictor of poor health outcomes among a national cohort of HIV/AIDS patients admitted to US hospitals: a cohort study. BMC Infect Dis. 2009; 9:127. PMC: 2736968. DOI: 10.1186/1471-2334-9-127. View

Moore R, Stanton D, Gopalan R, Chaisson R . Racial differences in the use of drug therapy for HIV disease in an urban community. N Engl J Med. 1994; 330(11):763-8. DOI: 10.1056/NEJM199403173301107. View

Easterbrook P, Keruly J, Richman D, Chaisson R, Moore R . Racial and ethnic differences in outcome in zidovudine-treated patients with advanced HIV disease. Zidovudine Epidemiology Study Group. JAMA. 1991; 266(19):2713-8. View

Oramasionwu C, Brown C, Lawson K, Ryan L, Skinner J, Frei C . Differences in national antiretroviral prescribing patterns between black and white patients with HIV/AIDS, 1996-2006. South Med J. 2011; 104(12):794-800. PMC: 3222681. DOI: 10.1097/SMJ.0b013e318236c23a. View

Brooks J, Kaplan J, Holmes K, Benson C, Pau A, Masur H . HIV-associated opportunistic infections--going, going, but not gone: the continued need for prevention and treatment guidelines. Clin Infect Dis. 2009; 48(5):609-11. DOI: 10.1086/596756. View

. HIV prevalence, unrecognized infection, and HIV testing among men who have sex with men--five U.S. cities, June 2004-April 2005. MMWR Morb Mortal Wkly Rep. 2005; 54(24):597-601. View

Law M, Hurley S, Carlin J, Chondros P, Gardiner S, Kaldor J . A comparison of patient interview data with pharmacy and medical records for patients with acquired immunodeficiency syndrome or human immunodeficiency virus infection. J Clin Epidemiol. 1996; 49(9):997-1002. DOI: 10.1016/0895-4356(96)00141-2. View

10.

Smith S, Kirking D . Access and use of medications in HIV disease. Health Serv Res. 1999; 34(1 Pt 1):123-44. PMC: 1088988. View

11.

Walensky R, Paltiel A, Losina E, Mercincavage L, Schackman B, Sax P . The survival benefits of AIDS treatment in the United States. J Infect Dis. 2006; 194(1):11-9. DOI: 10.1086/505147. View

12.

Fischl M, Dickinson G, La Voie L . Safety and efficacy of sulfamethoxazole and trimethoprim chemoprophylaxis for Pneumocystis carinii pneumonia in AIDS. JAMA. 1988; 259(8):1185-9. DOI: 10.1001/jama.259.8.1185. View

13.

Gebo K, Fleishman J, Reilly E, Moore R . High rates of primary Mycobacterium avium complex and Pneumocystis jiroveci prophylaxis in the United States. Med Care. 2005; 43(9 Suppl):III23-30. DOI: 10.1097/01.mlr.0000175631.34438.1e. View

14.

Solomon L, Stein M, Flynn C, Schuman P, Schoenbaum E, Moore J . Health services use by urban women with or at risk for HIV-1 infection: the HIV Epidemiology Research Study (HERS). J Acquir Immune Defic Syndr Hum Retrovirol. 1998; 17(3):253-61. DOI: 10.1097/00042560-199803010-00011. View

15.

Shapiro M, Morton S, McCaffrey D, Senterfitt J, Fleishman J, Perlman J . Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study. JAMA. 1999; 281(24):2305-15. DOI: 10.1001/jama.281.24.2305. View

16.

Cargill V, Stone V . HIV/AIDS: a minority health issue. Med Clin North Am. 2005; 89(4):895-912. DOI: 10.1016/j.mcna.2005.03.005. View

17.

Helms D, Weinstock H, Mahle K, Bernstein K, Furness B, Kent C . HIV testing frequency among men who have sex with men attending sexually transmitted disease clinics: implications for HIV prevention and surveillance. J Acquir Immune Defic Syndr. 2009; 50(3):320-6. DOI: 10.1097/QAI.0b013e3181945f03. View

18.

Gifford A, Cunningham W, Heslin K, Andersen R, Nakazono T, Lieu D . Participation in research and access to experimental treatments by HIV-infected patients. N Engl J Med. 2002; 346(18):1373-82. DOI: 10.1056/NEJMsa011565. View

19.

Palella Jr F, Delaney K, Moorman A, Loveless M, Fuhrer J, Satten G . Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998; 338(13):853-60. DOI: 10.1056/NEJM199803263381301. View

20.

Oramasionwu C, Brown C, Lawson K, Ryan L, Frei C . Evaluating HIV/AIDS disparities for blacks in the United States: a review of antiretroviral and mortality studies. J Natl Med Assoc. 2010; 101(12):1221-9. DOI: 10.1016/s0027-9684(15)31133-0. View